MedTrace Logo

Feasibility, Safety and Performance Evaluation of an Application Based Training Programme for Patients After a Stroke

NCT06449612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-08-29

No results posted yet for this study

Summary

The goal of this investigation is to evaluate the feasibility, safety and performance of an application-based training programme in patients after a stroke in the subacute phase.

* Is the training programme 'TeleRehaStroke' using the mobile application 'Blended Clinic' for patients after a stroke feasible and usable?
* How is the user experience of the mobile application-based training programme?

Participants will:

* Get to know the programme and use the application 'Blended Clinic' during their last weeks before discharge from the inpatient rehabilitation.
* Be guided through inpatient setting, transition and outpatient setting and be accompanied by a coaching therapist via the application.
* Continue to use the application for 12 weeks after discharge from rehabilitation.

Conditions

Interventions

DEVICE

TeleRehaStroke: Training programme using the 'Blended Clinic' mobile application

Primary end users (patients after stroke) will be familiarised with the application and the 'TeleRehaStroke' programme in two to three sessions during their last two to three weeks prior to discharge from the inpatient rehabilitation centre. This includes performing daily exercises, wearing an activity tracker and measuring blood pressure daily. Following discharge from rehabilitation, they will continue to use the application for 12 weeks.

Sponsors & Collaborators

  • Corina Schuster-Amft

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-26
Primary Completion
2025-07-29
Completion
2025-07-29

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06449612 on ClinicalTrials.gov